Spruce Biosciences, Inc. - Common Stock (SPRB)

Spruce Biosciences Inc is a biopharmaceutical company focused on the development of innovative therapies for patients with rare endocrine disorders

The company is committed to addressing unmet medical needs through the advancement of its proprietary drug candidates, particularly targeting conditions related to adrenal insufficiency. By harnessing cutting-edge scientific research and clinical expertise, Spruce aims to bring effective treatment options to patients, ultimately enhancing their quality of life and managing complex hormonal imbalances associated with these disorders.